Korrektur
Correction to “Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia”
Cancer · 15.03.2026 · 132 (6)
DOI: 10.1002/cncr.70347 ↗Kurz gefasst
Korrektur in der Zeitschrift Cancer, online erschienen am 13.03.2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Correction to “Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia”. Cancer, 132(6). https://doi.org/10.1002/cncr.70347
Vancouver
Correction to “Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia”. Cancer. 2026;132(6). doi:10.1002/cncr.70347
BibTeX
@article{euvimed2026,
title = {Correction to “Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia”},
journal = {Cancer},
year = {2026},
volume = {132},
number = {6},
doi = {10.1002/cncr.70347}
}
EUVIMED